Concurrent Chemoradiation and Durvalumab for Locoregionally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT04447612 · UNKNOWN
Trial details
- NCT number
- NCT04447612
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2023-12-31
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.